Gene: NDUFA8
Official Full Name: NADH:ubiquinone oxidoreductase subunit A8provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the complex I 19 kDa subunit family. Mammalian complex I is composed of 45 different subunits. This protein has NADH dehydrogenase activity and oxidoreductase activity. It plays an important role in transfering electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36446 | NDUFA8 Knockout cell line (HeLa) | Human | NDUFA8 | 1:3~1:6 | Negative | Online Inquiry |
KO36447 | NDUFA8 Knockout cell line (HCT 116) | Human | NDUFA8 | 1:2~1:4 | Negative | Online Inquiry |
KO36448 | NDUFA8 Knockout cell line (HEK293) | Human | NDUFA8 | 1:3~1:6 | Negative | Online Inquiry |
NDUFA8 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to disrupt the expression of the NDUFA8 gene, which encodes a critical subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase). This gene plays an essential role in the electron transport chain, facilitating ATP production through oxidative phosphorylation. By creating knockout variants, researchers can investigate the physiological and pathological implications of impaired mitochondrial function.
The primary function of these cell lines is to serve as invaluable tools in studying mitochondrial-related diseases, metabolic disorders, and the intricate mechanisms of energy metabolism. The absence of the NDUFA8 gene allows scientists to elucidate the contributions of complex I dysfunction to various disease states and cellular processes. These knockout cell lines have shown to be instrumental in drug discovery efforts aimed at developing therapeutics targeting mitochondrial dysfunction, as well as in evaluating the impact of nutritional influences on mitochondrial health.
The scientific importance of NDUFA8 Gene Knockout Cell Lines is underscored by their applicability in both basic and translational research settings. They serve as robust models for investigating the pathways involved in neurodegenerative diseases, cancer metabolism, and conditions linked to mitochondrial dysfunction. Compared to alternative models, these knockout lines provide more precise insights into the specific contributions of the NDUFA8 gene to cellular bioenergetics, representing a significant advancement in the study of mitochondrial biology.
The key advantages of using our NDUFA8 Gene Knockout Cell Lines include their validated performance, ease of use in standard laboratory protocols, and compatibility with a variety of assays, including high-throughput screening, which enhances the efficiency of research workflows. Their specificity ensures that researchers can confidently draw conclusions directly related to the NDUFA8 gene effects, leading to more impactful discoveries.
For researchers, clinicians, and academic institutions, investing in NDUFA8 Gene Knockout Cell Lines facilitates groundbreaking research into mitochondrial dysfunction and its broader implications in health and disease. With a commitment to excellence, our company specializes in providing high-quality, customizable genetic products that support innovative science and advance the field of biomedicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.